Mixed Polymeric Micelles for Paclitaxel Delivery: Preparation and Characterization
ACS Omega · 18.08.2026 · 11 (32) · 47765-47778
DOI: 10.1021/acsomega.6c03082 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 04.08.2026. Verfasst von Gisele L Maia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Products Faculty of Pharmacy, Federal University of Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte 31270-901, Mi…. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais, Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico, Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior.
Abstract (Originalsprache)
To address the limitations of commercial vehicles for paclitaxel (PTX) delivery, this study investigated mixed micelles as a novel delivery system for this drug. By incorporating PCL5000-PEG5000 into DSPE-PEG2000 at 99.5:0.5 and 99:1 molar ratios, we aimed to enhance drug loading and biocompatibility. The resulting systems were characterized using a range of physicochemical and biological characterization. The system achieved a low critical micelle concentration (CMC) of 1.9 × 10–5 mol/L, ensuring stability upon dilution. Optimized formulations (99.5:0.5 and 99:1 molar ratios) exhibited a small hydrodynamic diameter (∼11 nm) and near-neutral zeta potential. Small-range X-ray scattering (SAXS) analysis confirmed a spheroidal core–shell structure, where the addition of 0.5% PCL5000-PEG5000 increased drug loading capacity to 3.1 ± 0.05% w/w. Thermal analysis confirmed the successful integration of copolymers and their thermal stability. Notably, the cytotoxicity of this formulation was comparable to that of commercial formulations, while exhibiting negligible hemolysis (<2%), indicating a substantially improved safety profile compared with Cremophor-based vehicles. These findings highlight the potential of these mixed micelles as a biocompatible, high-capacity delivery platform for intravenous cancer chemotherapy.
Autor:innen und Institutionen
- Department of Pharmaceutical Products Faculty of Pharmacy, Federal University of Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil.
- Departmentof Physics (ICEx), Federal University of Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil.
- Department of Food and Drug, Faculty of Pharmaceutical Sciences, Federal University of Alfenas, Alfenas 37130-001, Minas Gerais, Brazil.
- Department of Clinical and Toxicological Analyses Faculty of Pharmacy, Federal University of Minas Gerais, Av. Antônio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil.
ORCID-Profile: Anna Carolina S Sousa, Angelo Malachias, Maria Betânia F Marques, André L B de Barros, Elaine A Leite
Förderung
- Funda??o de Amparo ? Pesquisa do Estado de Minas Gerais
- Conselho Nacional de Desenvolvimento Cient?fico e Tecnol?gico
- Coordena??o de Aperfei?oamento de Pessoal de N?vel Superior
Zitieren
APA
Maia, G. L., Sousa, A. C. S., Teixeira, M. X., Malachias, A., Machado, M. V. H., Marques, M. B. F., Oda, C. M. R., B de Barros, A. L., & Leite, E. A. (2026). Mixed Polymeric Micelles for Paclitaxel Delivery: Preparation and Characterization. ACS Omega, 11(32), 47765-47778. https://doi.org/10.1021/acsomega.6c03082
Vancouver
Maia GL, Sousa ACS, Teixeira MX, Malachias A, Machado MVH, Marques MBF, et al. Mixed Polymeric Micelles for Paclitaxel Delivery: Preparation and Characterization. ACS Omega. 2026;11(32):47765-47778. doi:10.1021/acsomega.6c03082
BibTeX
@article{Maia2026,
author = {Maia, Gisele L and Sousa, Anna Carolina S and Teixeira, Marina X and Malachias, Angelo and Machado, Maria Victoria H and Marques, Maria Betânia F and Oda, Caroline M R and B de Barros, André L and Leite, Elaine A},
title = {Mixed Polymeric Micelles for Paclitaxel Delivery: Preparation and Characterization},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {32},
pages = {47765--47778},
doi = {10.1021/acsomega.6c03082}
}
EUVIMED